TY - JOUR
T1 - Induction of autophagy by cystatin C
T2 - A mechanism that protects murine primary cortical neurons and neuronal cell lines
AU - Tizon, Belen
AU - Sahoo, Susmita
AU - Yu, Haung
AU - Gauthier, Sebastien
AU - Kumar, Asok R.
AU - Mohan, Panaiyur
AU - Figliola, Matthew
AU - Pawlik, Monika
AU - Grubb, Anders
AU - Uchiyama, Yasuo
AU - Bandyopadhyay, Urmi
AU - Cuervo, Ana Maria
AU - Nixon, Ralph A.
AU - Levy, Efrat
PY - 2010
Y1 - 2010
N2 - Cystatin C (CysC) expression in the brain is elevated in human patients with epilepsy, in animal models of neurodegenerative conditions, and in response to injury, but whether up-regulated CysC expression is a manifestation of neurodegeneration or a cellular repair response is not understood. This study demonstrates that human CysC is neuroprotective in cultures exposed to cytotoxic challenges, including nutritional-deprivation, colchicine, staurosporine, and oxidative stress. While CysC is a cysteine protease inhibitor, cathepsin B inhibition was not required for the neuroprotective action of CysC. Cells responded to CysC by inducing fully functional autophagy via the mTOR pathway, leading to enhanced proteolytic clearance of autophagy substrates by lysosomes. Neuroprotective effects of CysC were prevented by inhibiting autophagy with beclin 1 siRNA or 3-methyladenine. Our findings show that CysC plays a protective role under conditions of neuronal challenge by inducing autophagy via mTOR inhibition and are consistent with CysC being neuroprotective in neurodegenerative diseases. Thus, modulation of CysC expression has therapeutic implications for stroke, Alzheimer's disease, and other neurodegenerative disorders.
AB - Cystatin C (CysC) expression in the brain is elevated in human patients with epilepsy, in animal models of neurodegenerative conditions, and in response to injury, but whether up-regulated CysC expression is a manifestation of neurodegeneration or a cellular repair response is not understood. This study demonstrates that human CysC is neuroprotective in cultures exposed to cytotoxic challenges, including nutritional-deprivation, colchicine, staurosporine, and oxidative stress. While CysC is a cysteine protease inhibitor, cathepsin B inhibition was not required for the neuroprotective action of CysC. Cells responded to CysC by inducing fully functional autophagy via the mTOR pathway, leading to enhanced proteolytic clearance of autophagy substrates by lysosomes. Neuroprotective effects of CysC were prevented by inhibiting autophagy with beclin 1 siRNA or 3-methyladenine. Our findings show that CysC plays a protective role under conditions of neuronal challenge by inducing autophagy via mTOR inhibition and are consistent with CysC being neuroprotective in neurodegenerative diseases. Thus, modulation of CysC expression has therapeutic implications for stroke, Alzheimer's disease, and other neurodegenerative disorders.
UR - http://www.scopus.com/inward/record.url?scp=77956475769&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0009819
DO - 10.1371/journal.pone.0009819
M3 - Article
C2 - 20352108
AN - SCOPUS:77956475769
SN - 1932-6203
VL - 5
JO - PLoS ONE
JF - PLoS ONE
IS - 3
M1 - e9819
ER -